DERMAPHARM HOLDING SE (DMP.DE) Forecast, Price Target & Analyst Ratings
FRA:DMP • DE000A2GS5D8
38.4 EUR
+0.1 (+0.26%)
Last: Mar 6, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DERMAPHARM HOLDING SE (DMP.DE).
Forecast Snapshot
Consensus Price Target
€43.25
+ 12.62% Upside
Next Earnings Forecast
Release DateMar 17, 2026
ChartMill Buy Consensus
78.18%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€43.25
Upside
+ 12.62%
From current price of €38.40 to mean target of €43.25, Based on 11 analyst forecasts
Low
€34.34
Median
€44.88
High
€50.40
Price Target Revisions
1 Month
0.95%
3 Months
0.95%
Price Target Summary
11 analysts have analysed DMP.DE and the average price target is 43.25 EUR. This implies a price increase of 12.62% is expected in the next year compared to the current price of 38.4.
The average price target has been revised upward by 0.95% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
78.18%
DMP.DE was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about DMP.DE.
In the previous month the buy percentage consensus was at a similar level.
DMP.DE was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-07 | Berenberg | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 17, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.025B 8.68% | 1.135B 10.79% | 1.181B 4.00% | 1.192B 0.95% | 1.237B 3.78% | 1.282B 3.64% | 1.352B 5.46% | 1.394B 3.11% | 1.458B 4.59% | 1.446B -0.82% | 1.496B 3.46% | 1.548B 3.48% | |
| EBITDA YoY % growth | 378.35M 11.04% | 302.764M -19.98% | 314.578M 3.90% | 330.49M 5.06% | 346.17M 4.74% | 360.29M 4.08% | 354.43M -1.63% | 311.57M -12.09% | 437.74M 40.49% | N/A | N/A | N/A | |
| EBIT YoY % growth | 283.441M -4.07% | 200.992M -29.09% | 227.793M 13.33% | 235.13M 3.22% | 249.67M 6.18% | 263.29M 5.46% | 295.81M 12.35% | 276.38M -6.57% | 286.06M 3.50% | 295.93M 3.45% | 306.3M 3.50% | 316.86M 3.45% | |
| Operating Margin | 27.66% | 17.70% | 19.29% | 19.73% | 20.18% | 20.54% | 21.88% | 19.83% | 19.62% | 20.47% | 20.47% | 20.47% | |
| EPS YoY % growth | N/A -9.92% | N/A -36.10% | N/A -8.62% | 2.28 11.31% | 2.52 10.56% | 2.73 8.51% | 3.54 29.52% | N/A | N/A | N/A | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
10.12%
EPS Next 5 Year
14.68%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
2.23%
Revenue Next 5 Year
3.04%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
19.70%
EBIT Next 5 Year
8.20%
DERMAPHARM HOLDING SE / DMP.DE Forecast FAQ
Can you provide the average price target for DERMAPHARM HOLDING SE stock?
11 analysts have analysed DMP.DE and the average price target is 43.25 EUR. This implies a price increase of 12.62% is expected in the next year compared to the current price of 38.4.
Can you provide the upcoming earnings date for DERMAPHARM HOLDING SE?
DERMAPHARM HOLDING SE (DMP.DE) will report earnings on 2026-03-17, after the market close.
What is the number of analysts for DMP stock?
The number of analysts covering DERMAPHARM HOLDING SE (DMP.DE) is 11.